Related Experiment Video
Updated: Jan 21, 2026
07:55
Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
Published on: August 29, 2017
12.2K
Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance
Valerie J Kinchen1, Guido Massaccesi1, Andrew I Flyak2
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
The Journal of Clinical Investigation
|August 14, 2019
Summary
Developing a hepatitis C virus (HCV) vaccine is critical. Researchers identified specific broadly neutralizing antibody (bNAb) combinations in patients that correlate with HCV clearance, offering insights for vaccine design.
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- A vaccine for hepatitis C virus (HCV) is urgently needed.
- Broadly-neutralizing plasma antibodies during acute infection are linked to HCV clearance, but their specific viral targets (epitopes) remain unidentified.
- Identifying these epitopes is crucial for designing effective HCV vaccines that elicit specific neutralizing antibodies (NAbs).
Purpose of the Study:
- To develop and apply a high-throughput method for deconvoluting polyclonal anti-HCV NAbs in plasma.
- To delineate the epitope specificities of anti-HCV NAbs in individuals experiencing acute HCV infection.
- To identify bNAb combinations associated with viral clearance.
Main Methods:
- Development and application of a high-throughput assay to analyze polyclonal anti-HCV NAbs.
- Analysis of plasma samples from 44 individuals with acute HCV infection, assessing subsequent viral clearance or persistence.
- Delineation of epitope specificities for NAbs in patient plasma.
Main Results:
- Identification of multiple broadly neutralizing antibody (bNAb) combinations in acute HCV infection plasma.
- These bNAb combinations were associated with increased plasma neutralizing breadth.
- The identified bNAb combinations significantly correlated with spontaneous HCV clearance.
Conclusions:
- The study identified key bNAb combinations linked to natural HCV clearance.
- These findings can inform the development of novel HCV vaccine strategies by defining target bNAb specificities.
- A high-throughput assay was established for identifying potent neutralizing responses in future vaccine trials.
Related Concept Videos
01:09Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
483
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
483
01:14Hepatic Drug Clearance: Role of Transporters
303
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
303
01:09Hepatic Drug Clearance: Effect of Protein Binding
527
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
527
01:20Deconvolution
553
Deconvolution, also known as inverse filtering, is the process of extracting the impulse response from known input and output signals. This technique is vital in scenarios where the system's characteristics are unknown, and they must be inferred from the observable signals.
Deconvolution involves several mathematical techniques to derive the impulse response. One common approach is polynomial division. In this method, the input and output sequences are treated as coefficients of...
Deconvolution involves several mathematical techniques to derive the impulse response. One common approach is polynomial division. In this method, the input and output sequences are treated as coefficients of...
553
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
280
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
280
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
583
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
583